Depakote and pregnancy category

The U.S. Food and Drug Administration classified Depakote as a Pregnancy Category D drug due to its likelihood of causing serious and

be more safely used during pregnancy. Follow your doctor's instructions about taking Depakote while you are pregnant. If you take Depakote to prevent migraine headaches: FDA pregnancy category X. Do not use Depakote to prevent migraine headaches if you are pregnant.

There is new evidence that women who take Depakote during pregnancy are more likely to have a child with autism. Categories: Medical

Therapeutic classification: anticonvulsant. Pregnancy risk category D Doses of divalproex sodium (Depakote) and valproate sodium are expressed as valproic

Depakote was re-classified as a Pregnancy Category X drug in May 2024, following decades of increased evidence of birth defect risks. Depakote and Birth Defects.

Depakote's pregnancy category for migraine use will be changed from D (the potential benefit of the drug in pregnant women may be acceptable despite its

Depakote products will remain in pregnancy category D for treating epilepsy and manic episodes associated with bipolar disorder. Other brand names for

Avoid valproate, Depakote, in pregnancy. CHRIS AIKEN: Valproate is Paroxetine is the only SSRI with a category D warning, which it earned for

Tablets, enteric coated: Depakote, Depakote ER, Depakote Sprinkle, Divalproex, Epival (CAN) Classification: Antiepileptic Pregnancy Category D Dosage Route ADULTS. Dosage is expressed as valproic acid equivalents.